| Entry |
|
|---|
| Name |
Glovadalen (USAN/INN) |
|---|
| Formula |
C24H27Cl2N3O3
|
|---|
| Exact mass |
475.1429
|
|---|
| Mol weight |
476.39
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01467 Dopamine D1-receptor agonist
|
|---|
| Efficacy |
Antiparkinsonian, Dopamine receptor agonist |
|---|
| Comment |
Treatment of Parkinson's disease
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01467 Dopamine D1-receptor agonist
D13239 Glovadalen
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD1
D13239 Glovadalen (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 32
1 C8x C 13.7900 -14.4200
2 C8x C 13.7900 -15.8200
3 C8x C 14.9800 -16.5200
4 C8y C 16.2400 -15.8200
5 C8y C 16.2400 -14.4200
6 C8y C 14.9800 -13.7200
7 C1d C 14.9800 -12.3200
8 C1y C 17.4300 -16.5200
9 N1y N 18.6200 -15.8200
10 C1y C 18.6200 -14.4200
11 C1x C 17.4300 -13.7200
12 C1b C 19.8800 -13.7200
13 O1a O 21.0700 -14.4200
14 C5a C 19.8800 -16.5200
15 O5a O 21.0700 -15.8200
16 C1b C 19.8800 -17.9200
17 C8y C 21.0700 -18.6200
18 C8y C 21.0700 -20.0200
19 C8y C 22.2600 -20.7200
20 C8x C 23.4500 -20.0200
21 C8x C 23.4500 -18.6200
22 C8y C 22.2600 -17.9200
23 C1a C 17.4300 -17.9200
24 X Cl 22.2600 -16.5200
25 O1a O 14.9800 -10.9200
26 C1a C 16.3800 -12.3200
27 C1a C 13.5800 -12.3200
28 N4y N 21.9800 -22.0500
29 N5x N 20.5800 -22.1900
30 C8y C 20.0200 -20.9300
31 X Cl 18.6200 -20.6500
32 C1a C 22.9600 -23.1700
BOND 35
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 4 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 5 11 1
13 10 12 1 #Down
14 12 13 1
15 9 14 1
16 14 15 2
17 14 16 1
18 16 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 17 22 1
25 8 23 1 #Up
26 22 24 1
27 7 25 1
28 7 26 1
29 7 27 1
30 19 28 1
31 28 29 1
32 29 30 2
33 18 30 1
34 30 31 1
35 28 32 1
|
|---|
